Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Honorary Professor delivers inaugural lecture in the Faculty of Theology
2010-10-27

Prof. Peter Lampe.

Prof. Peter Lampe recently delivered his inaugural lecture as an Honorary Professor in the Department of New Testament in the Faculty of Theology of the University of the Free State (UFS).

The title of Prof. Lampe’s inaugural lecture was Theology and rhetorics: how do "res" and "verba" relate to each other, in which he addressed the fundamental question of the role and importance of words and the issue/content in theology. Can content simply be conveyed in any manner? Also in theology, Martin Luther observed that some theologians’ works contain words (verba) and those of others the content (res). In his inaugural lecture, Prof. Lampe pointed out that our knowledge of God/reality specifically has to be construed through the use of words. Words and terminology therefore have to be selected with circumspection. Res and verba stand in close relation to each other.

Prof. Lampe declared that in the post-modern world, a “competition” exists for the best constructed worldview and theologians could make a significant contribution to the construction of a better reality through better judgement of the words they use. 

Prof. Lampe, currently the Chair of New Testament Theology at the University of Heidelberg in Germany, has a rich and varied history in the field of theology. Having attained degrees in theology, philosophy and archaeology in Gottingen, Rome and Berne, Prof. Lampe has enjoyed an illustrious professional career. After receiving his Ph.D. at the University of Berne and teaching New Testament Studies there, Prof. Lampe held the Chairs of New Testament Studies in Virginia (USA) and History and Archaeology of Early Christians in Kiel (Germany), before being appointed to the post he currently holds.

In 2003 he was awarded the German Ecumenical Preaching Award and in Turkey he was the leader of an expedition that discovered the long-lost Montanist headquarters of Pepouza and Tymion.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept